Prosecution Insights
Last updated: October 25, 2026

Antheros Legal Advisors LLP

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

9 pending office actions • 5 clients • 8 examiners • 6 art units • 0 of 9 (0%) have an AI response strategy ready

Analysis

Antheros Legal Advisors LLP has 9 pending office actions in Medical Devices & Mechanical Engineering and 174 career applications. Its resolved allowance rate is 69.66%, with an average of 2.68 office actions per allowance. The profile provides a current docket measure alongside application and outcome data.

The allowance rate is the principal historical outcome indicator, while the office-action average describes the prosecution activity associated with matters reaching allowance. For practitioners, the figures support review of claim scope, amendment choices, and response strategy in medical device and mechanical matters. The pending cases may deserve particular attention to identify unresolved issues that could affect eventual outcomes.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=174 apps, methodology: how we score firms)

69.7%
Allowance Rate
n=174
+0.67σ
Allowance Rate (norm)
n=174
2.7
OAs to Allowance
n=62
-0.62σ
OAs to Allow (norm)
n=62
817 days
Time to Allowance
n=62
+46.5pp
Interview Lift
n=174
16.8%
RCE Rate
n=174
1.5%
Appeal Rate
n=174

Rejection Performance (% of received rejections ultimately overcome)

—
§101 Overcome
n=7 (min 20)
40.7%
§102 Overcome
n=27
53.2%
§103 Overcome
n=47
66.0%
§112 Overcome
n=53

Specialization & Scale

A61K, A61P, C07K
Top CPC Subclasses
61%
Top-3 CPC Share
n=174
7
Practitioners
n=174
24.9
Apps / Practitioner
n=174

Portfolio Summary

9
Total Pending OAs
7
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (56%)
3
Medium (33%)
1
Easy (11%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (11%)
§103 only1 (11%)
§112 only1 (11%)
Double-patenting + other2 (22%)
Multi-statute (no §101)4 (44%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
44% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
5
Mechanical / Eng
56% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CASLER, BRIAN L 2 79.2% +21.4%
HASTINGS, ALISON AZAR 1 62.5% +42.1%
ALSOMAIRY, SARAH ABDOALATIF 1 57.4% +30.7%
SHIM, MORGAN SANGJO 1 0.0% +0.0%
VARADARAJ, ARCHANA 1 80.0% +33.3%
EISEMAN, ADAM JARED 1 55.1% +27.7%
BORI, IBRAHIM D 1 43.9% +39.0%
HOFFA, ANGELA MARIE 1 67.7% +28.1%

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18888376 Substituted Amine Compounds, Compositions and Methods of Use HASTINGS, ALISON AZAR —
18638206 REMOTE DRIVE TECHNIQUES FOR MAGNETIC FIELD THERAPY CASLER, BRIAN L —
18638197 TRANSCRANIAL MAGNETIC STIMULATION USING ROTATING FIELD VECTORS CASLER, BRIAN L —
18418108 HANDHELD ELECTROENCEPHALOGRAPHY DEVICE SHIM, MORGAN SANGJO —
18415494 NANOPARTICLES AND METHODS OF USE VARADARAJ, ARCHANA —
18477517 ELECTROENCEPHALOGRAM SCORING AND REPORTING FOR TRANSCRANIAL MAGNETIC STIMULATION EISEMAN, ADAM JARED —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18447040 THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USE THEREOF BORI, IBRAHIM D 52d overdue
18888376 Substituted Amine Compounds, Compositions and Methods of Use HASTINGS, ALISON AZAR —
18818418 HUMANIZED ANTIBODIES AGAINST NECTIN-2 AND DRUG CONJUGATES THEREOF ALSOMAIRY, SARAH ABDOALATIF —
18638206 REMOTE DRIVE TECHNIQUES FOR MAGNETIC FIELD THERAPY CASLER, BRIAN L —
18638197 TRANSCRANIAL MAGNETIC STIMULATION USING ROTATING FIELD VECTORS CASLER, BRIAN L —
18415494 NANOPARTICLES AND METHODS OF USE VARADARAJ, ARCHANA —
18477517 ELECTROENCEPHALOGRAM SCORING AND REPORTING FOR TRANSCRANIAL MAGNETIC STIMULATION EISEMAN, ADAM JARED —
18298306 SYSTEMS AND METHODS FOR PROVIDING ALPHA BURST BRAIN STIMULATION HOFFA, ANGELA MARIE —

Client Portfolio (5 clients)

Top Art Units

Art UnitApps
37914
16271
16461
16581
16291
37991

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18888376 Substituted Amine Compounds, Compositions and Methods of Use Deep Apple Therapeutics, Inc. HASTINGS, ALISON AZAR 1627 §102§112 Non-Final OA — Pending Sep 18, 2024
18818418 HUMANIZED ANTIBODIES AGAINST NECTIN-2 AND DRUG CONJUGATES THEREOF Nectin Therapeutics Ltd. ALSOMAIRY, SARAH ABDOALATIF 1646 §112DP Non-Final OA — Pending Aug 28, 2024
18638206 REMOTE DRIVE TECHNIQUES FOR MAGNETIC FIELD THERAPY Wave Neuroscience, Inc. CASLER, BRIAN L 3791 §102§103 Non-Final OA — Pending Apr 17, 2024
18638197 TRANSCRANIAL MAGNETIC STIMULATION USING ROTATING FIELD VECTORS Wave Neuroscience, Inc. CASLER, BRIAN L 3791 §102§103§112 Non-Final OA — Pending Apr 17, 2024
18418108 HANDHELD ELECTROENCEPHALOGRAPHY DEVICE Wave Neuroscience, Inc. SHIM, MORGAN SANGJO 3791 §103 Non-Final OA — Pending Jan 19, 2024
18415494 NANOPARTICLES AND METHODS OF USE Qana Therapeutics Inc. VARADARAJ, ARCHANA 1658 §102§103 Non-Final OA — Pending Jan 17, 2024
18477517 ELECTROENCEPHALOGRAM SCORING AND REPORTING FOR TRANSCRANIAL MAGNETIC STIMULATION Wave Neuroscience, Inc. EISEMAN, ADAM JARED 3791 §101§102§103§112 Final Rejection — Pending Sep 28, 2023
18447040 THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USE THEREOF Tvardi Operating Company, Inc. BORI, IBRAHIM D 1629 §103§112DP Final Rejection 52d overdue Pending Aug 09, 2023
18298306 SYSTEMS AND METHODS FOR PROVIDING ALPHA BURST BRAIN STIMULATION Wave Neuroscience, Inc. HOFFA, ANGELA MARIE 3799 §112 Non-Final OA — Pending Apr 10, 2023

Managing Antheros Legal Advisors LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Antheros Legal Advisors LLP's patent allowance rate?

69.7% of resolved applications prosecuted by Antheros Legal Advisors LLP were allowed, across 174 applications in USPTO records.

How many office actions does Antheros Legal Advisors LLP average before allowance?

2.68 office actions per allowed application on average.

How many pending office actions does Antheros Legal Advisors LLP have?

9 pending office actions as of October 2026, for 5 clients, before 8 examiners in 6 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month